Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies
Description
CONCLUSION: A complete evaluation of the risks of SARS-CoV-2 for health must take non-fatal disease outcomes into account, particularly in young populations where they can be 2 orders of magnitude more frequent than deaths.